BREAKING
Importance
72
Trust
71
Urgency
95
COMMERCIAL
Lilly's obesity pill tops 7,000 prescriptions in fourth week, signals modest uptake - Reuters
Eli Lilly's obesity pill reached 7,000 prescriptions in its fourth week on the market. The number suggests a slow start compared to competing weight-loss drugs.
Analysis
Lilly's new weight-loss pill is selling slower than hoped. That could give rivals like Novo more time to catch up in the pill race.
- Lilly's obesity pill hit 7,000 prescriptions in its fourth week on the market
- Uptake looks slow versus other weight-loss drugs
Reuters Health1mo
Read